Help Us Carry Out the World’s First Scientific Study on LSD Microdosing
We’re raising money for a groundbreaking research project
Anecdotal reports about the benefits of microdosing with LSD number in the thousands, yet no scientific study has ever been conducted to validate them. Said to boost cognition, enhance mood, alleviate depression and increase creativity, microdosing is one of the most under-researched areas of not just psychedelic science, but mental health in general.
Realising one of her longest held ambitions, Amanda Feilding has now put together a highly original protocol which will incorporate the ancient Chinese game of Go. The study will not only categorise the effects of microdosing, but will also illuminate the neurological mechanisms behind these effects.
Read more about our LSD microdosing study
Set to be carried out as part of the Beckley/Imperial Research Programme, the study is being made possible thanks to a crowdfunding campaign launched this week by Fundamental.
Donate to the crowdfunding campaign
Join the Crowdfunding Campaign to Fund a Mental Health Revolution
Hear from the psychedelic researchers leading the studies
The Fundamental crowdfunding campaign is hoping to raise a total of $2 million to support four separate studies into the benefits of psychedelic compounds, with a view to making them medically available. These include studies on psilocybin as a treatment for both end-of-life anxiety and alcoholism at NYU School of Medicine, and a clinical trial of MDMA for post-traumatic stress disorder, led by the Multidisciplinary Association for Psychedelic Studies (MAPS).
Read more about the Beckley/Imperial LSD microdosing study.
Our LSD Microdosing Study in the Media
VICE Motherboard: ‘First-Ever LSD Microdosing Study Will Pit the Human Brain Against AI’
WIRED: Scientists Want You to Give Them Money to Study Psychedelics
DAILY MAIL: Can the Human Brain on LSD Take on AI?
Fund A Mental Health Revolution
How Can You Help?
“Not only is it difficult to raise money, but we have to raise rather a lot of money because the constraints of working with illegal drugs means that the expenses go up enormously.” – Professor David Nutt, co-director of the Beckley/Imperial Research Programme
To join this revolution in mental healthcare and help change the course of psychedelic research, donate to support the world’s first scientific study on LSD microdosing.
Or you can join the Beckley Foundation Crowdrise team and help us fundraise. Simply go to this page and click the big FUNDRAISE FOR THIS CAMPAIGN button and you’ll instantly have your own fundraising page as a part of our Team.
With very best wishes,
Amanda Feilding and the Beckley Foundation team
Psilocybin for Depression
Type of publication